Literature DB >> 16515601

Microsatellite instability in mitochondrial genome of common female cancers.

Y Wang1, V W S Liu, P C K Tsang, P M Chiu, A N Y Cheung, U S Khoo, P Nagley, H Y S Ngan.   

Abstract

To investigate the occurrence of mitochondrial genome instability in primary cervical, endometrial, ovarian, and breast carcinomas, we analyzed 12 microsatellite regions in mitochondrial DNA (mtDNA) of tumor tissues and their matched normal controls. Four of the 12 microsatellite markers starting at nucleotide position (np) 303, 514, 956, and 16184, respectively, exhibited instability as indicated by the change in length of short base-repetitive sequences of mtDNA in cancer tissue relative to that in control normal tissue from the same patient. About 25.4% of cervical cancers, 48.4% of endometrial cancers, 21.9% of ovarian cancers, and 29.4% of breast cancers carried one or more mitochondrial microsatellite instability (mtMSI). mtMSI was frequently detected in the D-loop region but rarely occurred in the coding region. A relatively long C tract interrupted by a T residue is the mtMSI hot spot in all four types of cancer studied. Different tumors have different mtMSI profiles. In particular, the frequency of mtMSI in endometrial cancer was significantly higher than in the other three types of cancer. Furthermore, carriers of a germ-line T to C polymorphism at np 16189 could be more susceptible to breast cancer development in light of the higher frequency detected in cancer patients than in normal individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515601     DOI: 10.1111/j.1525-1438.2006.00412.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  15 in total

1.  Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.

Authors:  Jae-Ho Lee; Tae-Yung Ryu; Chi-Heum Cho; Dae-Kwang Kim
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

Review 2.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

3.  Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest.

Authors:  Aleksandra Klemba; Magdalena Kowalewska; Wojciech Kukwa; Katarzyna Tonska; Aleksandra Szybinska; Malgorzata Mossakowska; Anna Scinska; Paweł Golik; Kamil Koper; Jakub Radziszewski; Andrzej Kukwa; Anna M Czarnecka; Ewa Bartnik
Journal:  J Biomed Sci       Date:  2010-09-08       Impact factor: 8.410

4.  Sequence variations of mitochondrial DNA D-loop region in patients with acute myeloid leukemia.

Authors:  Juan Zhou; Haimei Gou; Yuanxin Ye; Yi Zhou; Xiaojun Lu; Binwu Ying
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

Review 5.  Mitochondrial DNA mutations and breast tumorigenesis.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Biochim Biophys Acta       Date:  2013-10-16

6.  Mitochondrial D310 mutations in the early development of breast cancer.

Authors:  C Xu; D Tran-Thanh; C Ma; K May; J Jung; J Vecchiarelli; S J Done
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

7.  Review: mitochondrial defects in breast cancer.

Authors:  Josefa Salgado; Beatriz Honorato; Jesús García-Foncillas
Journal:  Clin Med Oncol       Date:  2008-04-01

8.  Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages.

Authors:  Felix O Aikhionbare; Sharifeh Mehrabi; K Kumaresan; Mojgan Zavareh; Moshood Olatinwo; Kunle Odunsi; Edward Partridge
Journal:  J Carcinog       Date:  2007-01-26

9.  Common mitochondrial polymorphisms as risk factor for endometrial cancer.

Authors:  Anna M Czarnecka; Aleksandra Klemba; Andrzej Semczuk; Katarzyna Plak; Barbara Marzec; Tomasz Krawczyk; Barbara Kofler; Pawel Golik; Ewa Bartnik
Journal:  Int Arch Med       Date:  2009-10-28

10.  mtDNA sequence variants in subtypes of epithelial ovarian cancer stages in relation to ethnic and age difference.

Authors:  Felix O Aikhionbare; Sharifeh Mehrabi; Winston Thompson; Xuebiao Yao; William Grizzle; Edward Partridge
Journal:  Diagn Pathol       Date:  2008-07-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.